Skip to main content
UniHealth

Doctor search

Roberto Jesus Bernardo, MD

Critical Care (Intensivists) · Stanford

NPI 1063853109

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · University Healthcare Alliance

Looking this up.

Hospitals listed: Good Samaritan Hospital · Indiana University Health · Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bernardo’s office to ask if they take your plan before you enroll.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Indiana University HealthIndianapolis, INAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Indiana University Health, which runs 14 hospitalsHome of Indiana University Melvin and Bren Simon Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 63% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.199, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.631, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.344, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Indiana University Health

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Indiana University Health
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.199BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.631BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.344BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.38 (0.74 to 2.02) · 4,418 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.87 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths170.2 (138.94 to 201.46) · 355 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 76 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7 · 112 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.5 · 136 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.8 · 325 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.1 · 457 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.7 · 628 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 6,141 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.33 (0.16 to 0.5) · 13,186 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.24 (0.07 to 0.41) · 13,815 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.31 (2.04 to 4.57) · 5,254 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.07 (1.06 to 3.09) · 2,685 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.89 (0.92 to 2.86) · 4,949 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths12.17 (8.96 to 15.38) · 2,533 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.96 (3.13 to 6.8) · 2,632 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.78 (0.63 to 2.93) · 1,570 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.51 (0.12 to 0.91) · 11,263 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 82 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections1.048No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.372No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.731No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits12.7 · 267 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits17.7 · 728 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-18 · 169 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits9.6 · 408 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits13.9 · 500 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.1 · 864 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5 (3.9 to 6.5) · 877 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.4 (7.8 to 11.5) · 877 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.4 · 74 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.1 · 100 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.9 · 291 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.8) · 210 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.1) · 1,074 casesNo differentJan 2024 – Dec 2024

What patients said (611 patients answered, 15% of those asked)

Patient survey stars by topic at Indiana University Health
Cleanliness1
Nurse communication2
Doctor communication3
Communication about medicines1
Discharge information3
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Indiana University Health
Room was "always" clean58%
Nurses "always" communicated well71%
Doctors "always" communicated well77%
Staff "always" explained49%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge84%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)60%
Staff "always" explained new medications63%
Nurses "always" explained things so they could understand65%
Nurses "always" listened carefully69%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital63%
Staff "always" explained possible side effects36%
Yes, staff "did" give patients information about possible symptoms87%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$48,902

Medicare paid this office $48,902 for 145 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Critical care, first 30-74 minutes84$27,534$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$8,646$86
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes29$3,351$96
Critical care, each additional 30 minutes22$2,262$78
Insertion of tube in right heart chambers for measurement18$1,650$92
See all 7 services
Every Original Medicare service billed
Critical care, first 30-74 minutes84$27,534$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$8,646$86
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes29$3,351$96
Critical care, each additional 30 minutes22$2,262$78
Insertion of tube in right heart chambers for measurement18$1,650$92
Ultrasonic guidance for blood vessel access17$172$10
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes16$132$8

Who their Medicare patients are

145 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 12% · Women 49% · Also on Medicaid 23% · Health risk score 2.41. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 75% · Heart failure 55% · Coronary heart disease 52% · Chronic kidney disease 51% · COPD 47% · Atrial fibrillation 46% · Diabetes 44% · Depression 39% · Cancer 23% · Stroke 23% · Dementia 15%.

The office billed $163,948, Medicare allowed $63,114 and paid $48,902; for 469 services of 24 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024145469712.41$163,948$48,902
2023132405703.16$273,542$46,166
2022188524682.57$461,256$62,062
2021226665673.20$533,731$83,698
202093304672.10$214,245$34,825

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Critical care, first 30-74 minutes66$32,142$162
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes22$3,920$91
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$970$61
Insertion of tube in right heart chambers for measurement11$913$83
Short return visit (20+ min)14$634$42
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes11$98$9

2022: 9 services

Original Medicare services billed in 2022
Critical care, first 30-74 minutes114$47,072$167
Insertion of tube in right heart chambers for measurement30$3,367$99
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes22$2,715$78
Short return visit (20+ min)15$1,301$68
Return visit (30+ min)11$1,159$97
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$927$51
Short return visit (20+ min)12$612$47
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes28$308$10
Ultrasonic guidance for blood vessel access19$233$11

2021: 9 services

Original Medicare services billed in 2021
Critical care, first 30-74 minutes119$63,341$169
Long return visit (40+ min)24$3,721$138
Insertion of tube in right heart chambers for measurement28$2,819$101
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$2,513$53
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes24$1,925$77
Critical care, each additional 30 minutes16$1,787$85
Return visit (30+ min)12$1,561$98
Drug infusion during cardiac catheterization13$992$76
Ultrasonic guidance for blood vessel access23$248$11

2020: 6 services

Original Medicare services billed in 2020
Critical care, first 30-74 minutes51$26,288$175
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$2,042$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$1,062$82
Test to measure rate of airflow11$141$12
Test to examine how well the lungs exchange gases11$80$7
Test to measure largest amount of air breathed in an out13$45$3

Medicaid work

$5,857 in 2024

Medicaid paid $5,857 for 72 billed services this clinician did in 2024, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES72$5,857
Medicaid work by year
202472112$5,857
2023249124$48,918
2022477131$149,745
2021273121$63,585
2020107125$29,036
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes249$48,918

2022

Largest Medicaid services in 2022
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes477$149,745

2021

Largest Medicaid services in 2021
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes273$63,585

2020

Largest Medicaid services in 2020
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes107$29,036

Drugs they prescribed that Part D paid

$3,005,666

Pharmacies billed $3,005,666 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 539) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.

232 generic and 307 brand-name prescriptions · $3,005,666 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Winrevair65$1,222,768$18,812
Opsumit54$692,307$12,821
Orenitram Er75$529,024$7,054
Adempas23$316,167$13,746
Jardiance55$51,658$939
See all 13 drugs
Every Part D drug this clinician prescribed
Winrevair65$1,222,768$18,812
Opsumit54$692,307$12,821
Orenitram Er75$529,024$7,054
Adempas23$316,167$13,746
Jardiance55$51,658$939
Ozempic14$16,102$1,150
Sildenafil Citrate38$3,553$93
Spironolactone39$520$13
Torsemide15$393$26
Potassium Chloride14$296$21
Gabapentin11$198$18
Carvedilol15$192$13
Furosemide11$53$5

Year by year

Part D prescribing by year
2024539500% (0)57%$3,005,666
202348158NoneNone$1,402,795
202239937None36%$971,364
2021208290% (0)30%$439,034
202027None0% (0)None$48,690
201940None0% (0)80%$73,936
201825None0% (0)60%$45,527
201740160% (0)None$4,838
201635549NoneNone$21,859
201526439NoneNone$12,543
2014151307% (11)23%$6,924
2013572019% (11)19%$2,240

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Opsumit30$399,343$13,311
Adempas13$173,777$13,367
Ambrisentan34$170,798$5,023
Orenitram Er24$142,363$5,932
Jardiance37$40,367$1,091
Farxiga19$25,553$1,345
Sildenafil Citrate23$4,175$182
Midodrine15$3,050$203
Spironolactone66$922$14
Ondansetron Odt15$444$30
Gabapentin19$230$12
Furosemide21$53$3

2022: 14 drugs

Part D drugs prescribed in 2022
Opsumit20$251,543$12,577
Ambrisentan38$201,426$5,301
Orenitram Er13$67,735$5,210
Farxiga27$25,589$948
Jardiance21$12,543$597
Trelegy Ellipta12$8,018$668
Sildenafil Citrate41$5,578$136
Midodrine21$4,681$223
Tadalafil13$1,000$77
Spironolactone27$562$21
Potassium Chloride14$476$34
Albuterol Sulfate Hfa11$392$36
Gabapentin12$132$11
Furosemide16$86$5

2021: 7 drugs

Part D drugs prescribed in 2021
Adempas12$141,844$11,820
Ambrisentan24$89,764$3,740
Midodrine14$1,163$83
Sildenafil Citrate21$1,137$54
Spironolactone14$692$49
Potassium Chloride16$595$37
Furosemide17$87$5

2016: 13 drugs

Part D drugs prescribed in 2016
Lumigan11$1,686$153
Atorvastatin20$404$20
Omeprazole17$214$13
Metformin18$184$10
Levothyroxine14$173$12
Gabapentin16$169$11
Losartan20$166$8
Simvastatin17$152$9
Amlodipine Besylate27$142$5
Warfarin12$100$8
Lisinopril20$85$4
Montelukast12$75$6
Glipizide11$43$4

2015: 5 drugs

Part D drugs prescribed in 2015
Atorvastatin29$327$11
Levothyroxine25$203$8
Lisinopril20$69$3
Buspirone11$69$6
Amlodipine Besylate17$44$3

2014: 2 drugs

Part D drugs prescribed in 2014
Amlodipine Besylate17$138$8
Omeprazole15$97$6

Money from drug and device companies

$46,827 in 2025

Industry payments by year
2025364$38,270$46,827
2024458$11,346$31,124
2023625$5,000$7,011
2022337$7,575$10,015
2021318None$819
202011None$38
20191656None$1,316

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Merck Sharp & DohmeWinrevair$45,447
56 payments
  • Consulting for Winrevair · 2025-12-17 · $930
  • Consulting · 2025-11-24 · $10,240
  • Travel · 2025-11-24 · $150
  • Meals for Winrevair · 2025-11-15 · $24
  • Meals for Winrevair · 2025-11-15 · $48
  • Meals for Winrevair · 2025-11-14 · $35
  • Travel for Winrevair · 2025-11-14 · $256
  • Meals for Winrevair · 2025-11-14 · $48
  • Meals for Winrevair · 2025-11-14 · $100
  • Travel for Winrevair · 2025-11-13 · $256
  • Travel for Winrevair · 2025-11-13 · $221
  • Travel for Winrevair · 2025-11-13 · $609
  • Travel for Winrevair · 2025-11-13 · $116
  • Consulting for Winrevair · 2025-09-29 · $698
  • Paid to speak or teach for Winrevair · 2025-09-10 · $5,760
  • Travel for Winrevair · 2025-09-10 · $150
  • Travel for Winrevair · 2025-08-27 · $676
  • Travel for Winrevair · 2025-08-27 · $967
  • Travel for Winrevair · 2025-08-27 · $203
  • Meals for Winrevair · 2025-08-27 · $105
  • Consulting for Winrevair · 2025-08-25 · $233
  • Consulting for Winrevair · 2025-08-25 · $233
  • Consulting · 2025-08-06 · $233
  • Consulting for Winrevair · 2025-07-23 · $465
  • Travel · 2025-07-01 · $150
  • Consulting · 2025-07-01 · $5,760
  • Travel for Winrevair · 2025-06-20 · $249
  • Meals for Winrevair · 2025-06-20 · $60
  • Meals for Winrevair · 2025-06-20 · $50
  • Meals for Winrevair · 2025-06-20 · $55
  • Travel for Winrevair · 2025-06-19 · $887
  • Travel for Winrevair · 2025-06-19 · $272
  • Meals for Winrevair · 2025-06-19 · $135
  • Meals · 2025-05-18 · $38
  • Consulting · 2025-05-14 · $1,600
  • Paid to speak or teach for Winrevair · 2025-03-19 · $5,760
  • Travel for Winrevair · 2025-03-13 · $150
  • Meals for Winrevair · 2025-03-08 · $65
  • Meals for Winrevair · 2025-03-08 · $60
  • Meals for Winrevair · 2025-03-08 · $55
  • Travel for Winrevair · 2025-03-07 · $229
  • Travel for Winrevair · 2025-03-07 · $79
  • Travel for Winrevair · 2025-03-07 · $169
  • Travel for Winrevair · 2025-03-07 · $641
  • Meals for Winrevair · 2025-03-07 · $150
  • Travel · 2025-02-12 · $150
  • Consulting · 2025-02-12 · $5,490
  • Travel for Winrevair · 2025-02-03 · $26
  • Meals for Winrevair · 2025-02-02 · $26
  • Travel for Winrevair · 2025-02-02 · $129
  • Meals for Winrevair · 2025-02-02 · $17
  • Travel for Winrevair · 2025-02-01 · $20
  • Meals for Winrevair · 2025-02-01 · $10
  • Travel for Winrevair · 2025-02-01 · $129
  • Meals for Winrevair · 2025-02-01 · $48
  • Meals · 2025-01-31 · $33
United TherapeuticsTyvaso$1,213
5 payments
  • Meals for Tyvaso · 2025-09-29 · $111
  • Meals · 2025-05-20 · $50
  • Meals · 2025-05-16 · $96
  • Meals · 2025-02-01 · $85
  • Consulting · 2025-01-02 · $870
Actelion Pharmaceuticals USOpsumit$168
3 payments
  • Education for Opsumit · 2025-05-29 · $79
  • Meals · 2025-05-18 · $60
  • Meals for Opsumit · 2025-01-30 · $29
See all 64 published payments
Every published payment
Merck Sharp & DohmeConsulting · 2025-12-17Winrevair$930
Merck Sharp & DohmeConsulting · 2025-11-24None$10,240
Merck Sharp & DohmeTravel · 2025-11-24None$150
Merck Sharp & DohmeMeals · 2025-11-15Winrevair$24
Merck Sharp & DohmeMeals · 2025-11-15Winrevair$48
Merck Sharp & DohmeMeals · 2025-11-14Winrevair$35
Merck Sharp & DohmeTravel · 2025-11-14Winrevair$256
Merck Sharp & DohmeMeals · 2025-11-14Winrevair$48
Merck Sharp & DohmeMeals · 2025-11-14Winrevair$100
Merck Sharp & DohmeTravel · 2025-11-13Winrevair$256
Merck Sharp & DohmeTravel · 2025-11-13Winrevair$221
Merck Sharp & DohmeTravel · 2025-11-13Winrevair$609
Merck Sharp & DohmeTravel · 2025-11-13Winrevair$116
Merck Sharp & DohmeConsulting · 2025-09-29Winrevair$698
United TherapeuticsMeals · 2025-09-29Tyvaso$111
Merck Sharp & DohmePaid to speak or teach · 2025-09-10Winrevair$5,760
Merck Sharp & DohmeTravel · 2025-09-10Winrevair$150
Merck Sharp & DohmeTravel · 2025-08-27Winrevair$676
Merck Sharp & DohmeTravel · 2025-08-27Winrevair$967
Merck Sharp & DohmeTravel · 2025-08-27Winrevair$203
Merck Sharp & DohmeMeals · 2025-08-27Winrevair$105
Merck Sharp & DohmeConsulting · 2025-08-25Winrevair$233
Merck Sharp & DohmeConsulting · 2025-08-25Winrevair$233
Merck Sharp & DohmeConsulting · 2025-08-06None$233
Merck Sharp & DohmeConsulting · 2025-07-23Winrevair$465
Merck Sharp & DohmeTravel · 2025-07-01None$150
Merck Sharp & DohmeConsulting · 2025-07-01None$5,760
Merck Sharp & DohmeTravel · 2025-06-20Winrevair$249
Merck Sharp & DohmeMeals · 2025-06-20Winrevair$60
Merck Sharp & DohmeMeals · 2025-06-20Winrevair$50
Merck Sharp & DohmeMeals · 2025-06-20Winrevair$55
Merck Sharp & DohmeTravel · 2025-06-19Winrevair$887
Merck Sharp & DohmeTravel · 2025-06-19Winrevair$272
Merck Sharp & DohmeMeals · 2025-06-19Winrevair$135
Actelion Pharmaceuticals USEducation · 2025-05-29Opsumit$79
United TherapeuticsMeals · 2025-05-20None$50
Actelion Pharmaceuticals USMeals · 2025-05-18None$60
Merck Sharp & DohmeMeals · 2025-05-18None$38
United TherapeuticsMeals · 2025-05-16None$96
Merck Sharp & DohmeConsulting · 2025-05-14None$1,600
Merck Sharp & DohmePaid to speak or teach · 2025-03-19Winrevair$5,760
Merck Sharp & DohmeTravel · 2025-03-13Winrevair$150
Merck Sharp & DohmeMeals · 2025-03-08Winrevair$65
Merck Sharp & DohmeMeals · 2025-03-08Winrevair$60
Merck Sharp & DohmeMeals · 2025-03-08Winrevair$55
Merck Sharp & DohmeTravel · 2025-03-07Winrevair$229
Merck Sharp & DohmeTravel · 2025-03-07Winrevair$79
Merck Sharp & DohmeTravel · 2025-03-07Winrevair$169
Merck Sharp & DohmeTravel · 2025-03-07Winrevair$641
Merck Sharp & DohmeMeals · 2025-03-07Winrevair$150
Merck Sharp & DohmeTravel · 2025-02-12None$150
Merck Sharp & DohmeConsulting · 2025-02-12None$5,490
Merck Sharp & DohmeTravel · 2025-02-03Winrevair$26
Merck Sharp & DohmeMeals · 2025-02-02Winrevair$26
Merck Sharp & DohmeTravel · 2025-02-02Winrevair$129
Merck Sharp & DohmeMeals · 2025-02-02Winrevair$17
Merck Sharp & DohmeTravel · 2025-02-01Winrevair$20
Merck Sharp & DohmeMeals · 2025-02-01Winrevair$10
Merck Sharp & DohmeTravel · 2025-02-01Winrevair$129
Merck Sharp & DohmeMeals · 2025-02-01Winrevair$48
United TherapeuticsMeals · 2025-02-01None$85
Merck Sharp & DohmeMeals · 2025-01-31None$33
Actelion Pharmaceuticals USMeals · 2025-01-30Opsumit$29
United TherapeuticsConsulting · 2025-01-02None$870
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $31,124

Payments by company in 2024
Actelion Pharmaceuticals USUptravi$18,790
12 payments
  • Travel · 2024-11-04 · $13,651
  • Meals for Uptravi · 2024-10-08 · $35
  • Education for Opsumit · 2024-07-22 · $89
  • Consulting for Uptravi · 2024-06-20 · $3,951
  • Meals for Uptravi · 2024-06-13 · $20
  • Meals for Uptravi · 2024-06-13 · $60
  • Meals · 2024-06-13 · $34
  • Meals for Uptravi · 2024-06-13 · $40
  • Meals for Uptravi · 2024-06-13 · $20
  • Meals for Uptravi · 2024-06-12 · $150
  • Travel for Uptravi · 2024-06-12 · $215
  • Travel for Uptravi · 2024-05-31 · $525
United TherapeuticsTyvaso$9,442
23 payments
  • Consulting · 2024-11-25 · $6,380
  • Meals · 2024-11-15 · $31
  • Travel · 2024-11-15 · $81
  • Meals · 2024-11-15 · $28
  • Travel · 2024-11-15 · $59
  • Meals · 2024-11-15 · $60
  • Meals · 2024-11-15 · $19
  • Meals · 2024-11-15 · $50
  • Meals · 2024-11-14 · $140
  • Meals · 2024-11-14 · $36
  • Travel · 2024-11-14 · $60
  • Travel · 2024-11-14 · $80
  • Travel · 2024-11-14 · $403
  • Meals · 2024-11-08 · $117
  • Travel · 2024-10-11 · $276
  • Meals for Orenitram · 2024-10-08 · $144
  • Meals for Tyvaso · 2024-10-08 · $37
  • Meals for Tyvaso · 2024-05-21 · $20
  • Meals for Remodulin · 2024-05-21 · $88
  • Meals · 2024-05-20 · $48
  • Consulting · 2024-03-11 · $1,015
  • Meals for Tyvaso · 2024-02-12 · $120
  • Meals for Tyvaso · 2024-01-15 · $150
Merck Sharp & DohmeWinrevair$2,850
22 payments
  • Meals for Winrevair · 2024-10-30 · $55
  • Travel for Winrevair · 2024-10-30 · $394
  • Meals for Winrevair · 2024-10-30 · $60
  • Meals for Winrevair · 2024-10-30 · $65
  • Meals for Winrevair · 2024-10-30 · $23
  • Travel for Winrevair · 2024-10-29 · $277
  • Travel for Winrevair · 2024-10-29 · $125
  • Meals for Winrevair · 2024-10-29 · $150
  • Meals for Winrevair · 2024-10-29 · $47
  • Travel for Winrevair · 2024-10-29 · $55
  • Travel for Winrevair · 2024-10-29 · $242
  • Meals · 2024-10-24 · $27
  • Meals · 2024-10-08 · $6
  • Travel for Winrevair · 2024-03-19 · $82
  • Meals for Winrevair · 2024-03-19 · $49
  • Meals for Winrevair · 2024-03-19 · $50
  • Meals for Winrevair · 2024-03-19 · $35
  • Meals for Winrevair · 2024-03-18 · $30
  • Meals for Winrevair · 2024-03-18 · $124
  • Travel for Winrevair · 2024-03-18 · $135
  • Travel for Winrevair · 2024-03-18 · $243
  • Travel for Winrevair · 2024-03-18 · $577
SandozTreprostinil$41
1 payment
  • Meals for Treprostinil · 2024-03-11 · $41

2023: $7,011

Payments by company in 2023
United TherapeuticsTyvaso$6,205
15 payments
  • Meals for Tyvaso · 2023-11-09 · $132
  • Meals for Remodulin · 2023-09-29 · $60
  • Meals for Tyvaso · 2023-08-17 · $35
  • Consulting · 2023-08-09 · $4,800
  • Meals · 2023-07-21 · $24
  • Meals · 2023-07-21 · $24
  • Meals · 2023-07-21 · $40
  • Meals · 2023-07-21 · $50
  • Meals · 2023-07-21 · $50
  • Travel · 2023-07-21 · $76
  • Meals · 2023-07-21 · $84
  • Travel · 2023-07-20 · $24
  • Travel · 2023-07-20 · $293
  • Travel · 2023-07-06 · $408
  • Meals for Tyvaso · 2023-04-06 · $106
Actelion Pharmaceuticals USUptravi$415
5 payments
  • Meals · 2023-09-29 · $36
  • Meals for Opsumit · 2023-08-03 · $119
  • Meals for Uptravi · 2023-03-05 · $43
  • Meals for Uptravi · 2023-03-05 · $80
  • Meals for Uptravi · 2023-01-17 · $138
Bayer Healthcare PharmaceuticalsAdempas$200
1 payment
  • Consulting for Adempas · 2023-10-25 · $200
Merck Sharp & DohmeNone$142
2 payments
  • Meals · 2023-09-29 · $58
  • Meals · 2023-08-24 · $85
SandozTreprostinil$26
1 payment
  • Meals for Treprostinil · 2023-09-30 · $26
Novo NordiskOzempic$22
1 payment
  • Meals for Ozempic · 2023-10-23 · $22

2022: $10,015

Payments by company in 2022
Actelion Pharmaceuticals USUptravi$9,118
11 payments
  • Meals · 2022-10-19 · $38
  • Meals · 2022-07-19 · $111
  • Meals for Uptravi · 2022-05-15 · $84
  • Consulting for Uptravi · 2022-05-14 · $2,020
  • Meals for Uptravi · 2022-05-14 · $65
  • Meals · 2022-04-28 · $205
  • Travel · 2022-04-28 · $156
  • Travel · 2022-04-28 · $735
  • Paid to speak or teach · 2022-04-26 · $5,555
  • Meals for Uptravi · 2022-02-16 · $125
  • Meals for Uptravi · 2022-02-16 · $25
United TherapeuticsTyvaso$753
25 payments
  • Meals · 2022-11-08 · $117
  • Meals for Tyvaso · 2022-10-16 · $12
  • Meals · 2022-08-18 · $123
  • Meals · 2022-06-14 · $98
  • Education · 2022-05-26 · $25
  • Meals for Tyvaso · 2022-05-13 · $51
  • Meals · 2022-04-22 · $12
  • Meals · 2022-04-22 · $2
  • Education · 2022-04-21 · $25
  • Education · 2022-04-21 · $25
  • Education for Tyvaso · 2022-04-21 · $25
  • Education for Remodulin · 2022-04-21 · $25
  • Education for Remodulin · 2022-04-21 · $25
  • Education · 2022-04-21 · $25
  • Education · 2022-04-21 · $15
  • Education · 2022-04-21 · $13
  • Meals for Tyvaso · 2022-04-18 · $116
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Tyvaso · 2022-03-30 · $3
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Orenitram · 2022-03-30 · $3
  • Education for Tyvaso · 2022-03-30 · $3
Merck Sharp & DohmeNone$145
1 payment
  • Meals · 2022-05-15 · $145

2021: $819

Payments by company in 2021
United TherapeuticsTyvaso$585
16 payments
  • Meals for Tyvaso · 2021-12-21 · $90
  • Education for Remodulin · 2021-12-01 · $117
  • Education for Remodulin · 2021-11-03 · $78
  • Education for Remodulin · 2021-11-02 · $13
  • Education for Remodulin · 2021-11-02 · $13
  • Education for Remodulin · 2021-11-02 · $8
  • Education for Remodulin · 2021-11-02 · $8
  • Education for Remodulin · 2021-11-02 · $8
  • Education for Remodulin · 2021-11-02 · $5
  • Education for Remodulin · 2021-11-02 · $3
  • Meals · 2021-10-22 · $6
  • Education for Remodulin · 2021-08-20 · $3
  • Education for Tyvaso · 2021-07-28 · $3
  • Education for Tyvaso · 2021-07-28 · $15
  • Meals for Tyvaso · 2021-06-02 · $106
  • Meals for Tyvaso · 2021-05-11 · $115
Actelion Pharmaceuticals USUptravi$119
1 payment
  • Meals for Uptravi · 2021-11-17 · $119
Mentor WorldwideMentor Memorygel Resterilizable Gel Sizer$114
1 payment
  • Meals for Mentor Memorygel Resterilizable Gel Sizer · 2021-09-21 · $114

2020: $38

Payments by company in 2020
United TherapeuticsNone$38
1 payment
  • Meals · 2020-01-10 · $38

2019: $1,316

Payments by company in 2019
Actelion Pharmaceuticals USUptravi$223
5 payments
  • Meals for Uptravi · 2019-05-23 · $97
  • Meals for Uptravi · 2019-05-16 · $35
  • Meals for Opsumit · 2019-04-25 · $40
  • Meals for Opsumit · 2019-02-14 · $28
  • Meals for Opsumit · 2019-01-24 · $23
AstraZeneca Pharmaceuticals LPFasenra$194
7 payments
  • Meals for Fasenra · 2019-06-12 · $12
  • Meals for Symbicort · 2019-05-31 · $11
  • Meals for Fasenra · 2019-04-19 · $11
  • Meals for Fasenra · 2019-03-25 · $126
  • Meals for Fasenra · 2019-03-08 · $11
  • Meals for Fasenra · 2019-01-28 · $12
  • Meals for Fasenra · 2019-01-18 · $11
GlaxoSmithKlineNucala$187
13 payments
  • Meals for Nucala · 2019-09-05 · $19
  • Meals for Nucala · 2019-06-21 · $19
  • Meals for Trelegy Ellipta · 2019-06-06 · $17
  • Meals for Anoro · 2019-05-23 · $10
  • Meals for Nucala · 2019-05-08 · $17
  • Meals for Anoro · 2019-04-26 · $12
  • Meals for Nucala · 2019-04-08 · $13
  • Meals for Trelegy Ellipta · 2019-04-04 · $11
  • Meals for Anoro · 2019-03-13 · $17
  • Meals for Nucala · 2019-03-11 · $14
  • Meals for Trelegy Ellipta · 2019-02-23 · $14
  • Meals for Anoro · 2019-02-06 · $8
  • Meals for Trelegy Ellipta · 2019-01-17 · $15
AllerganAvycaz$170
7 payments
  • Meals for Avycaz · 2019-09-11 · $25
  • Meals for Avycaz · 2019-06-14 · $24
  • Meals for Avycaz · 2019-05-30 · $24
  • Meals for Avycaz · 2019-04-10 · $24
  • Meals for Avycaz · 2019-03-14 · $25
  • Meals for Avycaz · 2019-02-18 · $24
  • Meals for Avycaz · 2019-01-31 · $25
Gilead SciencesNone$131
6 payments
  • Meals · 2019-06-10 · $20
  • Meals · 2019-05-30 · $27
  • Meals · 2019-05-06 · $23
  • Meals · 2019-03-28 · $21
  • Meals · 2019-03-06 · $19
  • Meals · 2019-02-07 · $22
United TherapeuticsOrenitram$99
2 payments
  • Meals for Orenitram · 2019-01-15 · $71
  • Meals for Orenitram · 2019-01-03 · $28
Bayer HealthCare PharmaceuticalsAdempas$69
4 payments
  • Meals for Adempas · 2019-06-07 · $19
  • Meals for Adempas · 2019-03-11 · $15
  • Meals for Adempas · 2019-02-01 · $16
  • Meals for Adempas · 2019-01-07 · $18
Boehringer Ingelheim PharmaceuticalsOfev$58
3 payments
  • Meals for Spiriva Respimat · 2019-03-29 · $18
  • Meals for Ofev · 2019-02-25 · $22
  • Meals for Ofev · 2019-01-30 · $19
EkosEkosonic$37
1 payment
  • Meals for Ekosonic · 2019-02-18 · $37
Portola PharmaceuticalsAndexxa$34
1 payment
  • Meals for Andexxa · 2019-06-13 · $34
Salix Pharmaceuticals a division of Bausch Health USXifaxan$26
2 payments
  • Meals for Xifaxan · 2019-05-28 · $15
  • Meals for Xifaxan · 2019-04-22 · $11
RelypsaVeltassa$20
1 payment
  • Meals for Veltassa · 2019-06-03 · $20
Chiesi USACleviprex$19
1 payment
  • Meals for Cleviprex · 2019-01-09 · $19
Edwards LifesciencesFlotrac Sensor$18
1 payment
  • Meals for Flotrac Sensor · 2019-04-13 · $18
Jazz PharmaceuticalsXyrem$16
1 payment
  • Meals for Xyrem · 2019-02-04 · $16
InsmedArikayce$15
1 payment
  • Meals for Arikayce · 2019-04-01 · $15

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Merck Sharp & Dohme LLC · A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-Ph Due To Heart Failure With Preserved Ejection Fraction Hfpef · 2024Their institution$126,046
United Therapeutics Corporation · 2024Their institution$100,000
Merck Sharp & Dohme LLC · A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-Ph Due To Heart Failure With Preserved Ejection F · 2025Their institution$90,060
United Therapeutics Corporation · A Phase 4, Prospective, Multicenter, Single-Arm Study of A Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy To Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: Artisan (Afterload Reduction To Improve Right Ventricular Structure and Function) · 2024Their institution$75,728
United Therapeutics Corporation · A Phase 4, Prospective, Multicenter, Single-Arm Study of A Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy To Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: Artisan (Afterload Reduction To Improve Right Ventricular Structure and Function) · 2025Their institution$32,507
Merck Sharp & Dohme LLC · A Phase 2, Multicenter, Single-Blinded, Randomized Study To Evaluate the Pharmacokinetics and Safety of Sotatercept Mk-7962 Administered Using Either A Weight-Based Or Weight-Banded Approach in Participants With Pulmonary Arterial Hypertension Pah on · 2025Their institution$21,167
Merck Sharp & Dohme LLC · A Phase 2, Multicenter, Single-Blinded, Randomized Study To Evaluate the Pharmacokinetics and Safety of Sotatercept Mk-7962 Administered Using Either A Weight-Based Or Weight-Banded Approach in Participants With Pulmonary Arterial Hypertension Pah on Standard of Care · 2024Their institution$20,860
United Therapeutics Corporation · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ralinepag To Evaluate Safety and Effects on Exercise Capacity Assessed By Cpet in Subjects With Who Group 1 Pulmonary Hypertension Who Recently Initiated Therapy · 2022Their institution$10,500
United Therapeutics Corporation · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ralinepag To Evaluate Safety and Effects on Exercise Capacity Assessed By Cpet in Subjects With Who Group 1 Pulmonary Hypertension Who Recently Initiated Therapy · 2023Their institution$3,303
Merck Sharp & Dohme LLC · A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-Ph Due To Heart Failure With Preserved Ejection Fraction Hfpef · 2023Their institution$1,742

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
71.7 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1063853109
Licence
AZ R74169, IN 01089650A
Group
Stanford Health Care · University Healthcare Alliance
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
Yes
Medicaid ID
IN 300074949
Taxonomy
Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2013-07-16
NPI last updated
2025-09-02
NPI record certified
2025-09-02

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304

This office lists an electronic records connection.